Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,158,000 | 1,605,000 | 988,000 | 342,000 | 1,192,000 |
Receivables | 1,520,000 | 1,421,000 | 1,126,000 | 972,000 | 1,063,000 |
Inventories | 223,000 | 205,000 | 154,000 | 126,000 | 123,000 |
TOTAL | $3,058,000 | $3,348,000 | $2,380,000 | $1,560,000 | $2,490,000 |
Non-Current Assets | |||||
PPE Net | 1,627,000 | 1,544,000 | 1,505,000 | 1,461,000 | 1,453,000 |
Investments And Advances | 521,000 | 480,000 | 495,000 | 496,000 | 482,000 |
Intangibles | 8,040,000 | 8,072,000 | 7,930,000 | 7,832,000 | 7,740,000 |
Other Non-Current Assets | 780,000 | 699,000 | 680,000 | 700,000 | 678,000 |
TOTAL | $10,968,000 | $10,795,000 | $10,610,000 | $10,489,000 | $10,353,000 |
Total Assets | $14,026,000 | $14,143,000 | $12,990,000 | $12,049,000 | $12,843,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 2,000 | 555,000 | 555,000 | 3,000 | 804,000 |
Accounts payable and accrued liabilities | 1,633,000 | 1,686,000 | 1,142,000 | 981,000 | 1,041,000 |
TOTAL | $1,776,000 | $2,389,000 | $1,843,000 | $1,129,000 | $1,990,000 |
Non-Current Liabilities | |||||
Long Term Debt | 4,013,000 | 4,018,000 | 4,020,000 | 4,033,000 | 3,966,000 |
aiOther Non-Current Liabilities | 1,391,000 | 1,267,000 | 1,238,000 | 1,184,000 | 1,188,000 |
TOTAL | $5,441,000 | $5,308,000 | $5,266,000 | $5,217,000 | $5,166,000 |
Total Liabilities | $7,217,000 | $7,697,000 | $7,109,000 | $6,346,000 | $7,156,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 133,455 | 134,766 | 134,303 | 133,732 | 133,455 |
Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
Retained earnings | 9,303,000 | 8,800,000 | 8,307,000 | 8,197,000 | 8,174,000 |
Other shareholders' equity | 29,000 | 4,000 | -5,000 | -12,000 | 7,000 |
TOTAL | $6,809,000 | $6,446,000 | $5,881,000 | $5,703,000 | $5,687,000 |
Total Liabilities And Equity | $14,026,000 | $14,143,000 | $12,990,000 | $12,049,000 | $12,843,000 |